Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Li, Zhenzhen  [Clear All Filters]
2018
Zhang W, Bai X, Zhao B, Li Y, Zhang Y, Li Z, Wang X, Luo L, Han F, Zhang J, et al. Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway. Exp Cell Res. 2018.
2020
Wang H, Gong Y, Liang L, Xiao L, Yi H, Ye M, Roy M, Xia J, Zhou W, Yang C, et al. Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway. Br J Haematol. 2020.
2021
Yi H, Liang L, Wang H, Luo S, Hu L, Wang Y, Shen X, Xiao L, Zhang Y, Peng H, et al. Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma. Cancer Lett. 2021.
2023
Ni C, Lou X, Yao X, Wang L, Wan J, Duan X, Liang J, Zhang K, Yang Y, Zhang L, et al. Author Correction: ZIP1 fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn transfer. Nat Commun. 2023;14(1):880.
Duan Y, Zhao Y, Li Z, Liu Z, Wang M, Wang X, Sun M, Song C, Yao Y. Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy. Eur J Med Chem. 2023;260:115770.
Li Z, He Z, Wang J, Kong G. RNA splicing factors in normal hematopoiesis and hematologic malignancies: novel therapeutic targets and strategies. J Leukoc Biol. 2023;113(2):149-163.